Cargando…
Urinary peptide panel for prognostic assessment of bladder cancer relapse
Non-invasive tools stratifying bladder cancer (BC) patients according to the risk of relapse are urgently needed to guide clinical intervention. As a follow-up to the previously published study on CE-MS-based urinary biomarkers for BC detection and recurrence monitoring, we expanded the investigatio...
Autores principales: | Krochmal, Magdalena, van Kessel, Kim E. M., Zwarthoff, Ellen C., Belczacka, Iwona, Pejchinovski, Martin, Vlahou, Antonia, Mischak, Harald, Frantzi, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529475/ https://www.ncbi.nlm.nih.gov/pubmed/31114012 http://dx.doi.org/10.1038/s41598-019-44129-y |
Ejemplares similares
-
Urinary CE-MS peptide marker pattern for detection of solid tumors
por: Belczacka, Iwona, et al.
Publicado: (2018) -
Author Correction: Urinary CE-MS peptide marker pattern for detection of solid tumors
por: Belczacka, Iwona, et al.
Publicado: (2019) -
Pathophysiological Implications of Urinary Peptides in Hepatocellular Carcinoma
por: Bannaga, Ayman, et al.
Publicado: (2021) -
Urinary proteome signature of Renal Cysts and Diabetes syndrome in children
por: Ricci, Pierbruno, et al.
Publicado: (2019) -
PeptiCKDdb—peptide- and protein-centric database for the investigation of genesis and progression of chronic kidney disease
por: Krochmal, Magdalena, et al.
Publicado: (2016)